NURS 6501 Week 7 Assignment; MindMap - Parkinson s Disease.
Document Preview
Unlock Full 3 Page Document Instantly.
Document Overview
Definition Risk Factors • Parkinson’s disease (PD) is a progressive Parkinson’s • Age: Primarily affects individuals over 60. neurodegenerative disorder characterized by loss of • o Genetic Predisposition: Family history and dopamine producing neurons in the brain, which Disease genetic mutations (e.g., LRRK2 are primarily responsible for movement control mutation). (Vázquez- Vélez & Zoghbi, 2021). • o Gender: Men are more likely to develop PD Etiology than women. • Causing a loss of dopamine‐producing • o Environmental Toxins: Pesticide exposure. Common Signs and Symptoms Pathophysiology • o Head injury: Previous head trauma can be • Resting tremor usually beginning neurons in the substantia nigra and • Loss of dopamine basal ganglia, leading to impairment of a risk factor for developing PD in one hand. producing cells in the (Vázquez- Vélez & Zoghbi, 2021). • Slowness of movement, difficulty motor control and coordination. initiating movement. substantia nigra results • Muscle stiffness and resistance in a decreased amount to passive movement. of dopamine in the brain, compromising the Complications Patient & Family Education Causative Factors • Difficulty maintaining basal ganglia's function • Periods of “stuck feet” during • Stress the significance of taking • Genetic mutations such as balance, resulting in falls in controlling movement walking. medicine on time to keep LRRK2 and SNCA, occurring frequently. • Loss of dopamine leads • Postural instability and symptoms under control. • Pesticides and herbicide • Memory loss, trouble imbalance. • Partake in regular physical concentrating, and an overall to an imbalance with environmental exposure may acetylcholine, resulting • Uncontrollable, involuntary activity. also factor in. decline in cognitive in rigidity, bradykinesia, movement. • Taking a balanced diet to help function. • Progressive dementia. manage weight and prevent • Additional risk factors • Depression, anxiety. and tremors (Morris et include head trauma and age al., 2024). • Depression and Anxiety: constipation. • Insomnia, frequent waking. Autonomic. • Connecting with support groups related degeneration(Foltynie • Constipation, urinary urgency • Abnormal aggregations of protein • Constipation, orthostatic can help provide emotional et al., 2024). (Morris et al., 2024). that build up within hypotension, and support. nerve cells, where they sexual dysfunction. • Recommend home can contribute to modifications. neuronal damage. Medical Treatment • levodopa/Carbidopa (Sinemet) Labs & Diagnostic Tests • Dopamine Agonists (e.g., Ropinirole, Pramipexole • Dopamine transporter scan (DAT Scan) for visualization of dopaminergic activity in the brain. • MAO-B Inhibitors (e.g., Rasagiline): Inhibit the breakdown of dopamine. • • COMT Inhibitors (e.g., Entacapone To rule out other neurological conditions an MRI or CT scan may be ordered. • • To rule out other conditions that may cause similar symptoms, such as metabolic disorders or Amantadine: Reduces motor symptoms and dyskinesia. • Deep Brain Stimulation (DBS): Pallidotomy and thalamotomy: infections, blood tests may be performed. • Physical and Occupational Therapy. • Speech Therapy (Foltynie et al., 2024).
Full content available after purchase or with an active subscription.
Related Products
Related Products
Academic Use Notice: This resource is provided strictly as study support material to help students review concepts, understand topic structure, and prepare their own original academic work responsibly. It is not intended to be submitted directly as a student's own work.